Reynoso Erika D, Elpek Kutlu G, Francisco Loise, Bronson Roderick, Bellemare-Pelletier Angélique, Sharpe Arlene H, Freeman Gordon J, Turley Shannon J
Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
J Immunol. 2009 Feb 15;182(4):2102-12. doi: 10.4049/jimmunol.0802769.
The B7 family member programmed death-1 ligand (PD-L1) has been shown to play an inhibitory role in the regulation of T cell responses in several organs. However, the role of PD-L1 in regulating tolerance to self-Ags of the small intestine has not been previously addressed. In this study, we investigated the role of PD-L1 in CD8(+) T cell tolerance to an intestinal epithelium-specific Ag using the iFABP-tOVA transgenic mouse model, in which OVA is expressed as a self-Ag throughout the small intestine. Using adoptive transfer of naive OVA-specific CD8(+) T cells, we show that loss of PD-1:PD-L1 signaling, by either Ab-mediated PD-L1 blockade or transfer of PD-1(-/-) T cells, leads to considerable expansion of OVA-specific CD8(+) T cells and their differentiation into effector cells capable of producing proinflammatory cytokines. A fatal CD8(+) T cell-mediated inflammatory response develops rapidly against the small bowel causing destruction of the epithelial barrier, severe blunting of intestinal villi, and recruitment and activation of myeloid cells. This response is highly specific because immune destruction selectively targets the small intestine but not other organs. Collectively, these results indicate that loss of the PD-1:PD-L1 inhibitory pathway breaks CD8(+) T cell tolerance to intestinal self-Ag, thus leading to severe enteric autoimmunity.
B7家族成员程序性死亡-1配体(PD-L1)已被证明在多个器官的T细胞反应调节中发挥抑制作用。然而,PD-L1在调节小肠对自身抗原的耐受性方面的作用此前尚未得到探讨。在本研究中,我们使用iFABP-tOVA转基因小鼠模型,研究了PD-L1在CD8(+) T细胞对肠上皮特异性抗原的耐受性中的作用,在该模型中,OVA在整个小肠中作为自身抗原表达。通过过继转移幼稚的OVA特异性CD8(+) T细胞,我们发现,通过抗体介导的PD-L1阻断或转移PD-1(-/-) T细胞导致PD-1:PD-L1信号缺失,会导致OVA特异性CD8(+) T细胞大量扩增,并分化为能够产生促炎细胞因子的效应细胞。一种致命的CD8(+) T细胞介导的炎症反应迅速针对小肠发生,导致上皮屏障破坏、肠绒毛严重变钝以及髓样细胞的募集和激活。这种反应具有高度特异性,因为免疫破坏选择性地靶向小肠而非其他器官。总体而言,这些结果表明,PD-1:PD-L1抑制途径的缺失打破了CD8(+) T细胞对肠道自身抗原的耐受性,从而导致严重的肠道自身免疫。